These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 33217139)

  • 21. [Advances in application of clustered regularly interspaced short palindromic repeats (CRISPR)/CRISPR-associated 9 system in stem cells research].
    Sun SJ; Huo JH; Geng ZJ; Sun XY; Fu XB
    Zhonghua Shao Shang Za Zhi; 2018 Apr; 34(4):253-256. PubMed ID: 29690746
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Gene Editing With TALEN and CRISPR/Cas in Rice.
    Bi H; Yang B
    Prog Mol Biol Transl Sci; 2017; 149():81-98. PubMed ID: 28712502
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Generation of new glutinous rice by CRISPR/Cas9-targeted mutagenesis of the Waxy gene in elite rice varieties.
    Zhang J; Zhang H; Botella JR; Zhu JK
    J Integr Plant Biol; 2018 May; 60(5):369-375. PubMed ID: 29210506
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Multiplex CRISPR Mutagenesis of the Serine/Arginine-Rich (SR) Gene Family in Rice.
    Butt H; Piatek A; Li L; S N Reddy A; M Mahfouz M
    Genes (Basel); 2019 Aug; 10(8):. PubMed ID: 31394891
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Gene replacements and insertions in rice by intron targeting using CRISPR-Cas9.
    Li J; Meng X; Zong Y; Chen K; Zhang H; Liu J; Li J; Gao C
    Nat Plants; 2016 Sep; 2():16139. PubMed ID: 27618611
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cas9-NG Greatly Expands the Targeting Scope of the Genome-Editing Toolkit by Recognizing NG and Other Atypical PAMs in Rice.
    Ren B; Liu L; Li S; Kuang Y; Wang J; Zhang D; Zhou X; Lin H; Zhou H
    Mol Plant; 2019 Jul; 12(7):1015-1026. PubMed ID: 30928635
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Advances in therapeutic CRISPR/Cas9 genome editing.
    Savić N; Schwank G
    Transl Res; 2016 Feb; 168():15-21. PubMed ID: 26470680
    [TBL] [Abstract][Full Text] [Related]  

  • 28. CRISPR-Cas9 for cancer therapy: Opportunities and challenges.
    Chen M; Mao A; Xu M; Weng Q; Mao J; Ji J
    Cancer Lett; 2019 Apr; 447():48-55. PubMed ID: 30684591
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cutting Edge Genetics: CRISPR/Cas9 Editing of Plant Genomes.
    Soyars CL; Peterson BA; Burr CA; Nimchuk ZL
    Plant Cell Physiol; 2018 Aug; 59(8):1608-1620. PubMed ID: 29912402
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Analysis of microsatellite instability in CRISPR/Cas9 editing mice.
    Huo X; Du Y; Lu J; Guo M; Li Z; Zhang S; Li X; Chen Z; Du X
    Mutat Res; 2017 Mar; 797-799():1-6. PubMed ID: 28284774
    [TBL] [Abstract][Full Text] [Related]  

  • 31. CRISPR screens beyond Cas9.
    Burgess DJ
    Nat Rev Genet; 2020 May; 21(5):273. PubMed ID: 32235908
    [No Abstract]   [Full Text] [Related]  

  • 32. CRISPR/Cas9-mediated genome editing induces exon skipping by complete or stochastic altering splicing in the migratory locust.
    Chen D; Tang JX; Li B; Hou L; Wang X; Kang L
    BMC Biotechnol; 2018 Sep; 18(1):60. PubMed ID: 30253761
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Creation of DMD Muscle Cell Model Using CRISPR-Cas9 Genome Editing to Test the Efficacy of Antisense-Mediated Exon Skipping.
    Maruyama R; Yokota T
    Methods Mol Biol; 2018; 1828():165-171. PubMed ID: 30171541
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Harnessing CRISPR-Cas systems for bacterial genome editing.
    Selle K; Barrangou R
    Trends Microbiol; 2015 Apr; 23(4):225-32. PubMed ID: 25698413
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Rapid generation of genetic diversity by multiplex CRISPR/Cas9 genome editing in rice.
    Shen L; Hua Y; Fu Y; Li J; Liu Q; Jiao X; Xin G; Wang J; Wang X; Yan C; Wang K
    Sci China Life Sci; 2017 May; 60(5):506-515. PubMed ID: 28349304
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A simple and efficient method for CRISPR/Cas9-induced mutant screening.
    Hua Y; Wang C; Huang J; Wang K
    J Genet Genomics; 2017 Apr; 44(4):207-213. PubMed ID: 28416245
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Use of CRISPR/Cas9 gene-editing tools for developing models in drug discovery.
    Ahmad G; Amiji M
    Drug Discov Today; 2018 Mar; 23(3):519-533. PubMed ID: 29326075
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effective screen of CRISPR/Cas9-induced mutants in rice by single-strand conformation polymorphism.
    Zheng X; Yang S; Zhang D; Zhong Z; Tang X; Deng K; Zhou J; Qi Y; Zhang Y
    Plant Cell Rep; 2016 Jul; 35(7):1545-54. PubMed ID: 27007717
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The CRISPR/Cas9 system: Their delivery, in vivo and ex vivo applications and clinical development by startups.
    Song M
    Biotechnol Prog; 2017 Jul; 33(4):1035-1045. PubMed ID: 28440027
    [TBL] [Abstract][Full Text] [Related]  

  • 40. CRISPR-Cas9 System: Opportunities and Concerns.
    Vasiliou SK; Diamandis EP; Church GM; Greely HT; Baylis F; Thompson C; Schmitt-Ulms G
    Clin Chem; 2016 Oct; 62(10):1304-11. PubMed ID: 27551006
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.